Saag MS - Search Results

1

Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.

May MT, Hogg RS, Justice AC, Shepherd BE, Costagliola D, Ledergerber B, Thiébaut R, Gill MJ, Kirk O, van Sighem A, Saag MS, Navarro G, Sobrino-Vegas P, Lampe F, Ingle S, Guest JL, Crane HM, D'Arminio Monforte A, Vehreschild JJ, Sterne JA; Antiretroviral Therapy Cohort Collaboration (ART-CC). May MT, et al. Among authors: saag ms. Int J Epidemiol. 2012 Dec;41(6):1807-20. doi: 10.1093/ije/dys164. Epub 2012 Nov 12. Int J Epidemiol. 2012. PMID: 23148105 Free PMC article.

2

Pathogenicity and diversity of HIV and implications for clinical management: a review.

Saag MS, Hammer SM, Lange JM. Saag MS, et al. J Acquir Immune Defic Syndr (1988). 1994;7 Suppl 2:S2-10; discussion S10-1. J Acquir Immune Defic Syndr (1988). 1994. PMID: 7965648 Review.

3

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Sáag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. Carpenter CC, et al. Among authors: saag ms. JAMA. 1996 Jul 10;276(2):146-54. JAMA. 1996. PMID: 8656507 Review.

4

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel.

Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. Carpenter CC, et al. Among authors: saag ms. JAMA. 1997 Jun 25;277(24):1962-9. JAMA. 1997. PMID: 9200638

5

Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy.

Marschner IC, Collier AC, Coombs RW, D'Aquila RT, DeGruttola V, Fischl MA, Hammer SM, Hughes MD, Johnson VA, Katzenstein DA, Richman DD, Smeaton LM, Spector SA, Saag MS. Marschner IC, et al. Among authors: saag ms. J Infect Dis. 1998 Jan;177(1):40-7. doi: 10.1086/513823. J Infect Dis. 1998. PMID: 9419168 Clinical Trial.

6

Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data.

Ioannidis JP, Collier AC, Cooper DA, Corey L, Fiddian AP, Gazzard BG, Griffiths PD, Contopoulos-Ioannidis DG, Lau J, Pavia AT, Saag MS, Spruance SL, Youle MS. Ioannidis JP, et al. Among authors: saag ms. J Infect Dis. 1998 Aug;178(2):349-59. doi: 10.1086/515621. J Infect Dis. 1998. PMID: 9697714

7

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel.

Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. Carpenter CC, et al. Among authors: saag ms. JAMA. 2000 Jan 19;283(3):381-90. doi: 10.1001/jama.283.3.381. JAMA. 2000. PMID: 10647802 Review.

8

Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infection.

Call SA, Saag MS, Westfall AO, Raper JL, Pham SV, Tolson JM, Hellmann NS, Cloud GA, Johnson VA. Call SA, et al. Among authors: saag ms. J Infect Dis. 2001 Feb 1;183(3):401-8. doi: 10.1086/318078. Epub 2000 Dec 29. J Infect Dis. 2001. PMID: 11133371

9

Health-related quality of life and virologic outcomes in an HIV clinic.

Call SA, Klapow JC, Stewart KE, Westfall AO, Mallinger AP, DeMasi RA, Centor R, Saag MS. Call SA, et al. Among authors: saag ms. Qual Life Res. 2000;9(9):977-85. doi: 10.1023/a:1016668802328. Qual Life Res. 2000. PMID: 11332226

10

Immunologic and virologic consequences of temporary antiretroviral treatment interruption in clinical practice.

Chen RY, Westfall AO, Raper JL, Cloud GA, Chatham AK, Acosta EP, Pham SV, Tolson JM, Heudebert GR, Saag MS. Chen RY, et al. Among authors: saag ms. AIDS Res Hum Retroviruses. 2002 Sep 1;18(13):909-16. doi: 10.1089/088922202760265588. AIDS Res Hum Retroviruses. 2002. PMID: 12230934

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

508 results

Search Page